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ABSTRACT
INTRODUCTION: The hydrolytic stability of the calcium channel blocker representative diltiazem hy-
drochloride in the presence of different polymeric entourage was quantitatively assessed using HPLC.
AIM: The experiment was performed in order to establish drug-excipients compatibility in Poloxamer 407 
hydrogel formulations, where the drug was introduced either by a direct (conventional) approach or in the 
form of Eudragit RS microsponge-type particles with sustained drug release. 
MATERIALS AND METHODS: Samples of conventional diltiazem 2% hydrogel and microsponge-en-
riched diltiazem 2% hydrogel were stored at 25±2oC for 10 months, protected from light. Analysis of the 
chemical decomposition rate of diltiazem hydrochloride to its desacetyl degradant - O-desacetyl-diltia-
zem hydrochloride - was performed in the period between 4th and 10th month of storage.
RESULTS AND DISCUSSION: It was hypothesized that a polymeric “shield” of Eudragit RS in the com-
position of diltiazem-loaded porous microspheres and/or the enhanced viscosity achieved by the addition 
of high-molecular gelling agent Poloxamer 407 to an aqueous drug dispersion will benefit the drug’s stabil-
ity. Instead, a negative effect on the hydrolysis rate was found to be dominant for both polymers, likely due 
to an “unfavorable” shift in the dielectric conductivity of the media and/or suspected catalytic effect of qua-
ternary ammonium groups of Eudragit RS.
CONCLUSION: These preliminary results led us 
to a deeper understanding of the polymeric impact 
on diltiazem hydrolytic behavior and a very useful 
foundation for a future preformulation stage in the 
development of diltiazem modified-release semi-
solid forms for the treatment of chronic anal fis-
sure.
Keywords: diltiazem hydrolysis, diltiazem stabil-
ity, drug-excipient compatibility, polymeric drug 
delivery, HPLC
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INTRODUCTION
The chemical stability of an active pharma-
ceutical ingredient is of critical value for the dosage 
forms endurance and shelf life. Hydrolysis, as a com-
mon process leading to drug decomposition, affects 
primarily ester, amide, imide, thioester, lactam, and 
lactone functional groups. The kinetics and mecha-
nism of the hydrolytic process depend on intrinsic 
(related to the nature of the drug compounds) and 
external (environmental) factors. Important com-
pound-related factors are the type of hydrolytical-
ly unstable bond (e.g., ester, amide etc.), electrophi-
licity of the carbonyl C-atom, substituents by and 
around the same, steric stabilization, potential for 
intramolecular catalysis, ionizability, ability of the 
leaving group (e.g., alcohol), polymorphism and re-
active surface area (drug particle size). The most im-
portant among external factors are the temperature, 
pH, moisture/water content, water mobility, ion-
ic strength, presence of catalytically active ions and 
functional groups (intermolecular catalysis), dielec-
tric constant, and type of drug dispersion (e.g., a so-
lution or a suspension). All variables belonging to the 
group of environmental factors (with the exception 
of temperature) may be a function of the excipients 
used in a dosage form (1).
It was of our interest to follow the impact of 
two commonly used polymers in the pharmaceuti-
cal industry - Poloxamer 407 and ammonio metacry-
late copolymer Type B (Eudragit RS) on the hydrolytic 
degradation of diltiazem hydrochloride – a vasodila-
tor of the calcium channel blocker group - in hydro-
gel dispersions. 
The latter are applicable in the treatment of 
chronic anal fissure (CAF), but are most often pre-
pared ex tempore, given the low stability of the com-
pound in a hydrated environment and respective 
short shelf life.
Essential for the hydrolytic degradation of dilti-
azem is its acetyl oxide radical (2). Hydrolysis of the 
CH3COO-radical results in the formation of equimo-
lar amounts of O-desacetyl diltiazem (des-diltiazem) 
and acetic acid (Fig. 1) (3,4). Des-diltiazem possess-
es only quarter to half of the pharmacological activ-
ity of the parent drug molecule (5,6). The relatively 
high hydrolytic stability of the 7-membered lactam 
ring of diltiazem, on the other side, is likely due to a 
steric stabilization. Maximal stability and lowest rate 
of hydrolysis of diltiazem hydrochloride are reported 
at low-pH values in the range 3-5 (1,4,7).
In addition, under the influence of UV-Vis elec-
tromagnetic radiation, diltiazem is found to epimer-
ize reversibly to its (+)-(2R, 3S)-trans diltiazem an-
tipode, owing significantly lower coronaro-dilator 
ability (8,9). The photoinstability of diltiazem should 
be considered when choosing a primary packaging 
for the substance in bulk and diltiazem containing 
dosage forms (1).
The high reactivity and low hydrolytic stability 
of diltiazem occurs both in vitro (during storage) and 
in vivo (after intake). The latter manifests as low re-
sistance to esterases and other enzymes (10). Respec-
tively, diltiazem owns a short biological half-life (t1/2) 
and oral bioavailability (F) (t1/2 3-4.5 h; F≈40%) (4-6). 
In this view, there is a pharmacokinetic prerequisite 
to formulate diltiazem in modified-release dosage 
forms. The same applies when it comes to rectal dil-Scheme 1. Structure of diltiazem hydrochloride
Fig. 1. Hydrolysis of diltiazem to des-diltiazem 
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tiazem dosage forms. In this case, the sustained drug 
release overcomes some drawbacks showed by the 
conventional topical diltiazem hydrochloride formu-
lations for the treatment of CAF. A sustained drug 
delivery form of Eudragit RS microsponge-based Po-
loxamer diltiazem 2% hydrogels demonstrated a bet-
ter drug deposition in rectal mucosa and lower ab-
sorption, thus declaring the potency to reduce anal 
pruritus and postural hypotension caused by fast 
dissolution and absorption of diltiazem hydrochlo-
ride (11). 
AIM
The aim of the current survey was to assess the 
impact of the used polymers – Eudragit RS and Po-
loxamer 407 - on diltiazem with respect to its hydro-
lytic stability. 
MATERIALS AND METHODS
1. Materials – Chemicals and reagents were ob-
tained from (as follows): diltiazem hydrochlo-
ride 99.9% - Puho Pharmaceuticals Co. Lim-
ited, China; desacetyl diltiazem hydrochloride 
– LGC GmbH, Germany; ammonio methac-
rylate copolymer (type B) (Eudragit RS 100) - 
Evonik Industries AG, Germany; Poloxamer 
407 (Lutrol F-127) – BASF, Germany; Ethanol 
Absolute HPLC grade and Methanol HPLC 
grade – Fisher Chemical, Germany; ortho-
phosphoric acid > 85% - Fisher Scientific, UK. 
2. Preparation of diltiazem 2% gels – two types 
of diltiazem 2% gels were prepared, using gel 
base Poloxamer 407 20%: 
1. Diltiazem 2% Poloxamer 20% hydrogel (Px-
Dtz-gel), where the drug was introduced in the gel 
base via water solution (direct approach) and 
2. Microsponge-enriched diltiazem 2% 
Poloxamer 20% hydrogel (micro-Px-Dtz-gel), where 
the drug was introduced in the gel base via diltiazem-
loaded Eudragit RS 100 microsponge-type particles. 
Reference for the descriptive preparation 
techniques (for the gels formulation and the synthesis 
of diltiazem-loaded microsponge-type carriers) is 
available in our previous works (11-13). Sample of 
each formula was stored at 25±2oC in the dark for 
a period of 10 months. A standard diltiazem 2% 
solution in distilled water was used as reference; it 
was stored and tested under the same conditions. 
3. Preparation of standard solutions – stan-
dard stock solutions of diltiazem and des-
diltiazem were prepared in methanol at con-
centration of 100 µg/mL. Dilutions were per-
formed by mixing both stock solutions in 
gradient percent ratios from 0% to 100% by 
a step of 10%. Standard calibration curves of 
diltiazem and des-diltiazem were built by us-
ing HPLC data. 
4. Preparation of test solutions - 0.500 g of each 
test gel was dissolved in sufficient volume of 
methanol and further diluted up to 25.0 ml in 
a volumetric f lask. Proper dilution with the 
same solvent was carried, where it was nec-
essary, to obtain a theoretical concentration 
in the calibration range. The reference diltia-
zem 2% water solution was also analyzed af-
ter proper dilution, only with distilled water.
5. Analytical procedure – HPLC analysis – the 
stability tests were assayed by a Thermo Sci-
entific UltiMate 3000 Analytical LC System, 
coupled with a Thermo Scientific Dionex Ul-
tiMate 3000 VWD-3100 Variable Wavelength 
Detector, following the procedure validated 
by Sadeghiet et al (3). The column – a Ther-
mo scientific AQUASIL C18 (150 mm х 4.6 
mm, 5 µm) and guard column - AQUASIL 
C18 (10 mm х 4.6 mm, 5 µm) - were settled 
at 50oC. The test samples were introduced in 
a volume of 10 µL. The mobile phase (etha-
nol: aq. phosphoric acid with pH 2.2 - 35:65) 
was injected in an isocratic mode with a con-
stant f low rate of 1.2 mL/min. The total run 
time was 8 minutes. The detector was set at 
238 nm. The peak areas were integrated auto-
matically with the aid of a Thermo Scientific™ 
Chromeleon™ 7.2 Chromatography Data Sys-
tem software.
RESULTS AND DISCUSSION
The chromatograms obtained with des-diltia-
zem standard solution (100 µg/mL) and diltiazem 75 
µg/mL: des-diltiazem 25 µg/mL mixture are shown 
on Fig. 2. Retention times for des-diltiazem and dil-
tiazem were found at 2.6 min and 3.3 min, respec-
tively. Standard curves for both compounds, as de-
scribed above, were obtained in the concentration 
range of 10-100 µg/mL (Fig. 3).
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The observed test samples showed substantial-
ly different degradation rates of diltiazem, decreasing 
in the order Poloxamer 20%/ Eudragit RS-based hy-
drogel (micro-Px-Dtz-gel)> Poloxamer 20% hydrogel 
(Px-Dtz-gel)>water solution. Fig. 4 presents the chro-
matograms obtained for each diltiazem dispersion, 
following the decrease in the parent drug peak area 
and the increase in the degradation product – des-
diltiazem – peak area with the time. Under the stud-
ied conditions, no other degradation products of dil-
tiazem were detected. 
The change in the des-diltiazem content as a 
function of time for each dispersion is shown graph-
ically on Fig. 5a. When diltiazem was introduced in 
a Poloxamer gel, it showed faster initial decomposi-
tion rate compared to its aqueous solution. Knowing 
the relatively great chemical inertness of the hydro-
gel polymer (Fig. 6a), such escalation of the hydro-
lysis process could be only explained with the shift 
in the dielectric conductivity of the media. Further 
decomposition acceleration was observed when the 
drug was included in the hydrogel via Eudragit RS 
100 sustained-release microparticles. Eudragit RS, 
also known with its pharmacopoeial name ammonio 
methacrylate copolymer Type B, contains 4.5 to 7.0 
per cent quaternary ammonia 2-(trimethylammonio) 
ethyl 2-methylpropenoate groups (Fig. 6b) (14). Being 
positively charged, Eudragit RS could be perceived as 
potential catalyst of the diltiazem hydrolytic degra-
dation (1). The net negative effect on diltiazem sta-
bility was demonstrated to be only initial. After the 
4th month of storage, a linear steady-state increase in 
des-diltiazem concentration was reached. The kinet-
Fig. 2. Chromatograms of a) des-diltiazem standard so-
lution 100 µg/L and b) diltiazem 75 µg/mL: des-diltiazem 
25 µg/ml mixture
Fig. 3. Standard calibration curves of a) diltiazem and b) 
des-diltiazem
Fig. 4. Chromatograms of test formulations obtained at 
4th, 6th and 10th month of storing
Fig. 5. a) Increase in des-diltiazem concentration (% degradation) with time in test formulations; b) linear regression of 
the hydrolytic degradation using the data between the 4th and the 10th month of the study
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ic constant (k) of the process is lowest for the micro-
Px-Dtz-gel formulation (0.48% increase in des-dilti-
azem concentration per month) and highest for the 
aqueous solution (0.55%/month) at this stage (Figure 
6b). The observed phenomena is likely to be a result 
of a prevail of a viscosity based stabilization and a 
polymer “shield” determined stabilization after the 
4th month. 
CONCLUSION
The complex kinetics of diltiazem hydrolysis 
in Poloxamer 407 gels suggest the presence of more 
than one factor with impact on the process. Usual-
ly, when this is the case, the concentration of the hy-
drolytic product increases in a polymodal manner, 
which turns the mathematical extrapolation of the 
experimental data in a complicated task. In our case, 
the polymodality of the des-diltiazem curves could 
be explained with the role of the polymer ingredients 
in the systems. The polymers – Poloxamer 407 and 
Eudragit RS - play a role of both - drug carriers and 
participants in the phase distribution, transition and 
dispersity of diltiazem. Hence, their physicochemical 
properties (crystallinity, stability, solubility, gelation, 
cross-linkаge, etc.) and affinity to the drug molecule 
will be the factors determining the rate and order of 
diltiazem hydrolysis. Again, the intermolecular ca-
talysis is not excluded, especially in the case of Eu-
dragit RS-enriched gels. 
Despite the lack of complete straightforward-
ness in the results, the main conclusions to be drawn 
are: 
1. Diltiazem possesses complex decomposition 
kinetics in Poloxamer 407 hydrogels (with 
or without Eudragit RS microsponges); like-
ly due to the influence of multiple factors on 
the hydrolysis process, related to the impact 
of drug nature and concentration, polymer 
participation and phase distribution.
2. The enhanced viscosity of hydrogels was not 
found to benefit the hydrolysis stability of 
diltiazem.
3. The incorporation of diltiazem in a sus-
tained-release microsponge drug delivery 
system composed by Eudragit RS did not 
demonstrate the expected protection effect 
against the environmental hydrates. This ob-
servation was explained with the possible cat-
alytic effect of cationic Eudragit RS centers on 
the hydrolysis of diltiazem. 
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